Extracted information includes baseline characteristics (histologic features, Eastern Cooperative Oncology Group (ECOG) performance, PD-L1 tumor proportion score), efficacy outcomes (overall response rate, overall survival, progression-free survival), and safety endpoints (adverse events). Here, CD274 is linked to neoplasm.